trending Market Intelligence /marketintelligence/en/news-insights/trending/IOoQAbP7qQlLmCEgFoO6fg2 content esgSubNav
In This List

Verastem appoints chief medical officer

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Verastem appoints chief medical officer

Verastem Inc. appointed NgocDiep Le as chief medical officer.

Le joins Verastem from AstraZeneca PLC unit MedImmune Inc. where she served as vice president, immuno-oncology innovative medicines.

She previously served as global clinical program head and executive medical director at Novartis AG's oncology unit.